Catapres-TTS-3 Transdermal and Formoterol and mometasone

• Generic Name: clonidine
• Dosage Forms: patch, extended release
• Other Brand Names:

  Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3, Catapres, Catapres-TTS, Duraclon, Kapvay

Clonidine transdermal is used alone or together with other medicines to treat high blood pressure (hypertension). High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. High blood pressure may also increase the risk for heart attacks. These problems may be less likely to occur if the blood pressure is controlled.

Clonidine belongs to the class of medicines called antihypertensives. It works in the brain to change some of the nerve impulses. As a result, the blood vessels relax and blood passes through them more easily, which lowers blood pressure. When the blood pressure is lowered, the amount of blood and oxygen going to the heart is increased.

This medicine will not cure your high blood pressure, but it does help control it. Therefore, you must continue to use it as directed if you expect to lower your blood pressure and keep it down. You might have to take high blood pressure medicine for the rest of your life.

This medicine is available only with your doctor's prescription.

• Generic Name: formoterol / mometasone
• Dosage Forms: n.a.
• Other Brand Names: Dulera

Formoterol is a long-acting bronchodilator. Mometasone is a steroid.

Formoterol and mometasone is a combination medicine used to control and prevent the symptoms of asthma in adults and children at least 5 years old.

Formoterol when used alone may increase the risk of death in people with asthma. However, this risk is not increased when formoterol and mometasone are used together as a combination product.

Formoterol and mometasone may also be used for purposes not listed in this medication guide.